Protein and messenger RNA expression of connexin43 in astrocytomas: Implications in brain tumor gene therapy

Journal of Neurosurgery

Volumn 84, Issue 5, 1996, Pages 839-846

  Shinoura, Nobusada ^a   Chen, Lin ^a   Wani, Maqsood A ^a   Kim, Young Gyu ^a   Larson, Jeffrey J ^a   Warnick, Ronald E ^a   Simon, Matthias ^a   Menon, Anil G ^a   Bi, Wan Li ^a   Stambrook, Peter J ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

astrocytoma; bystander effect; connexin43; gap junction; gene therapy; glioblastoma

Indexed keywords

CONNEXIN 43; GANCICLOVIR; MESSENGER RNA; THYMIDINE KINASE;

ARTICLE; ASTROCYTOMA; CELL JUNCTION; CONTROLLED STUDY; DNA TRANSFECTION; GENE THERAPY; GLIOBLASTOMA; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RETROVIRUS;

EID: 15844409182     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.84.5.0839     Document Type: Article

References (41)

1. Beyer EC, Paul DL, Goodenough DA: Connexin43: a protein from rat heart homologous to a gap junction protein from liver. J Cell Biol 105:2621-2629. 1987
2. Bi WL, Parysek LM, Warnick R, et al: In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gene Ther 4:725-731, 1993
3. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
4. Culver KW, Ram Z, Wallbridge S, et al: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256:1550-1552, 1992
5. Culver KW, Van Gilder J, Link CJ, et al: Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum Gene Ther 5:343-379, 1994
6. Dermietzel R, Hertzberg EL, Kessler JA, et al: Gap junctions between cultured astrocytes: immunocytochemical, molecular, and electrophysiological analysis. J Neurosci 11:1421-1423, 1991
7. Dermietzel R, Traub O, Hwang TK, et al: Differential expression of three gap junction proteins in developing and mature brain tissues. Proc Natl Acad Sci USA 86:10148-10152, 1989
8. Eghbali B, Kessler JA, Reid LM, et al: Involvement of gap junctions in tumorigenesis: transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proc Natl Acad Sci USA 88:10701-10705, 1991
9. El-Sabban ME, Pauli BU: Cytoplasmic dye transfer between metastatic tumor cells and vascular endothelium. J Cell Biol 115:1375-1382, 1991
10. Freeman SM, Abboud CN. Whartenby KA, et al: The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53:5274-5283, 1993
11. Giaume C, Fromaget C, el Aoumari A, et al: Gap junctions in cultured astrocytes: single-channel currents and characterization of channel-forming protein. Neuron 6:133-143, 1991
12. Gross JL, Behrens DL, Mullins DE, et al: Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. Cancer Res 48:291-296, 1988
13. Hendrix EM, Mao SJT, Everson W, et al: Myometrial connexin 43 trafficking and gap junction assembly at term and in preterm labor. Mol Reprod Dev 33:27-38, 1992
14. Hossain MZ, Murphy LJ, Hertzberg EL, et al: Phosphorylated forms of connexin43 predominate in rat brain: demonstration by rapid inactivation of brain metabolism. J Neurochem 62: 2394-2403, 1994
15. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3:255-268, 1993
16. Laird DW, Puranam KL, Revel JP: Identification of intermediate forms of connexin43 in rat cardiac myocytes. in Hall JE. Zampigh GA, Davis RM (eds): Gap Junctions. Amsterdam: Elsevier, 1993, pp 263-268
17. Laird DW, Puranam KL, Revel JP: Turnover and phosphorylation dynamics of connexin43 gap junction protein in cultured cardiac myocytes. Biochem J 273:67-72, 1991
18. Larson DM, Haudenschild CC, Beyer EC: Gap junction messenger RNA expression by vascular wall cells. Circ Res 66: 1074-1080, 1990
19. Loewenstein WR, Kanno Y: Intercellular communication and the control of tissue growth: lack of communication between cancer cells. Nature 209:1248-1249, 1966
20. Loewenstein WR, Kanno Y: Studies on an epithelial (gland) cell junction. 1. Modifications of surface membrane permeability. J Cell Biol 22:565-586, 1964
21. Mehta PP, Bertram JS, Loewenstein WR: Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell 44:187-196, 1986
22. Mehta PP, Holz-Wagenblatt A, Rose B, et al: Incorporation of the gene for a cell-cell channel protein into transformed cells leads to normalization of growth. J Membr Biol 124:207-225, 1991
23. Micevych PE, Abelson L: Distribution of mRNAs coding for liver and heart gap junction proteins in the rat central nervous system. J Comp Neurol 305:96-118, 1991
24. Moolten FL: Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 46:5276-5281, 1986
25. Morgenstern JP, Land H: Advanced mammalian gene transfer: high titer retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18:3578-3596, 1990
26. Musil LS, Cunningham BA. Edelman GM, et al: Differential phosphorylation of the gap junction protein connexin43 in Junetional communication-competent and -deficient cell lines. J Cell Biol 111:2077-2088, 1990
27. Musil LS, Goodenough DA: Multisubunit assembly of an integral plasma membrane channel protein, gap junction connexin43, occurs after exit from the ER. Cell 74:1065-1077, 1993
28. Naus CCG, Elisevich K, Zhu D, et al: In vivo growth of C6 glioma cells transfected with connexin43 cDNA. Cancer Res 52:4208-4213, 1992
29. Nicholson B, Dermietzel R, Teplow D, et al: Two homologous protein components of hepatic gap junctions. Nature 329: 732-734, 1987
30. Nicolson GL, Dulski KM, Trosko JE: Loss of intercellular junctional communication correlates with metastatic potential in mammary adenocarcinoma cells. Proc Natl Acad Sci USA 85:473-476, 1988
31. Owens RB, Smith HS, Nelson-Rees WA. et al: Epithelial cell cultures from normal and cancerous human tissues. J Natl Cancer Inst 56:843-849, 1976
32. Pontén J. Macintyre EH: Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand 74:465-486, 1968
33. Puranam KL, Laird DW, Revel JP: Trapping an intermediate form of connexin43 in the golgi. Exp Cell Res 206:85-92, 1993
34. Rose B, Mehta PP, Loewenstein WR: Gap-junction protein gene suppresses tumorigenicity. Carcinogenesis 14: 1073-1075, 1993
35. Seiden RF: Analysis of RNA by Northern hybridization, in Ausubel FM, Brent R. Kingston RE. et al (eds): Current Protocols in Molecular Biology, ed 2. New York: John Wiley & Sons, 1992, pp 4-23-4-25
36. Stein GH: T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro. J Cell Physiol 99:43-54, 1979
37. Traub O, Look J, Dermietzel R. et al: Comparative characterization of the 21-kD and 26-kD gap junction proteins in murine liver and cultured hepatocytes. J Cell Biol 108:1039-1051. 1989
38. Wilgenbus KK, Kirkpatrick CJ, Knuechel R, et al: Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int J Cancer 51:522-529, 1992
39. Yamamoto T, Ochalski A, Hertzberg EL, et al: On the organization of astrocytic gap junctions in rat brain as suggested by LM and EM immunohistochemistry of connexin43 expression. J Corap Neurol 302:853-883, 1990
40. Yamamoto T, Shiosaka S, Whittaker ME, et al: Gap junction protein in rat hippocampus: light microscope immunohistochemical localization. J Comp Neurol 281:269-281, 1989
41. Zhu D, Caveney S, Kidder GM, et al: Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation. Proc Natl Acad Sci USA 88:1883-1887, 1991